theglobeandmail.comSEP 51 min read$NA

Canaccord Genuity Remains a Hold on Nano Labs Ltd. Sponsored ADR Class A (NA)

Canaccord Genuity reiterated a Hold rating on Nano Labs Ltd. ADR (NA), with shares closing at $2.24. The company reported Q4 revenue of $27.01B and net profit of $135.47B, up from $7.93M revenue and a $27.98M loss last year. Insider sentiment is negative, with 33 insiders selling shares.

Original reporting

theglobeandmail.com

Published Sep 5, 2026, 4:36 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 6, 2026, 3:32 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Canaccord Genuity Remains a Hold on Nano Labs Ltd. Sponsored ADR Class A (NA) — source image — Source · theglobeandmail.com

Decision brief

The 30-second read

$NANeutralMed

Why it matters

Earnings beat and insider sell provide new data for traders.

Market read

First report of Nano Labs' quarterly results and insider activity.

What to watch

Potential accounting anomalies given the huge swing from prior year.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

Canaccord Genuity maintains a Hold rating on Nano Labs ADR.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$NANeutralMedium confidence

Context

Nano Labs reported Q4 revenue of $27.01 B and net profit of $135.47 B, plus a director sold 11,165 shares for $25,146.

Expected impact

Potential short‑term volatility; price may dip on insider sell despite earnings beat.

Evidence & confidence

Large revenue beat could attract buyers, but negative insider sentiment may pressure the stock.

Market effects

Sector

Highlights strength in Nano Labs' sector, may lift peers.

Regional

Limited to markets tracking ADRs.

Global

Modest, as Nano Labs is a niche player.

Counterpoint

What could challenge this read

Insider selling suggests overvaluation despite earnings beat.

Key entities

Company
Nano Labs Ltd.
Issuer of ADR NA.
Director
Hu Nan
Insider who sold shares.

Read at source ← All news

AUG 31

$TDMedAI 8/10

Canada’s Big 6 banks sweep Q3 earnings estimates, but market reaction is mixed

Canada’s Big 6 banks all beat Q3 earnings estimates, with EPS surprises ranging from +5.9% to +13.1%. Despite the beats, three banks saw stock declines, while Scotiabank surged. Analysts have raised EPS estimates, and tailwinds include stabilizing margins and strong capital markets. Forward growth estimates range from +7.7% to +12.4%.

investing.com2 min

AUG 28

$NAMed

Nano Labs Ltd (NA): Financial results for H1 2026

Nano Labs Ltd (NA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Nano Labs Announces First Half of 2026 Financial Results HONG KONG, August 28, 2026 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure provider and crypto treasury company, today announced its unaudit

SEC EDGAR 6-K2 min

AUG 27

$BNSHighAI 8/10

RBC, CIBC, TD Bank, BMO, National Bank and Scotiabank: A breakdown of the big banks’ third-quarter earnings

Canada's major banks reported Q3 earnings, with all six beating analysts' expectations. Scotiabank (BNS) saw a 17% profit increase, BMO (BMO) reported a 25% decline but beat estimates, and RBC (RY) posted an 11% rise. National Bank (NA), CIBC (CM), and TD Bank (TD) also reported higher profits. Canadian bank stocks have risen 24% this year.

theglobeandmail.com2 min

AUG 26

$NAHighAI 8/10

National Bank posts higher quarterly profit, beating analysts’ expectations

National Bank of Canada reported a 23% increase in Q3 net income to $1.31B, or $3.25 per share, exceeding analysts' expectations. Adjusted earnings were $3.39 per share, beating estimates. Revenue rose 18% to $4.05B, while expenses increased 9% to $2.09B. The bank set aside $246M for credit losses. Profits grew across personal/commercial banking, capital markets, and wealth management.

theglobeandmail.com2 min

AUG 12

$BMOMed

Wednesday’s analyst upgrades and downgrades

TD Cowen analyst Mario Mendonca (TD Cowen) warns Canadian bank multiples could compress as operating leverage and revenue growth moderate, citing CMRR growth slowing and flat NIMs in 2028. He raised targets for BMO, CIBC, and RBC, and adjusted BNS and NB. Raymond James analyst Stephen Boland also updated Big 6 targets. Desjardins analyst Benoit Poirier said Cargojet shares rose after results.

theglobeandmail.com7 min

JUL 8